The Asia Pacific transient protein expression market was valued at US$ 181.05 million in 2023 and is expected to reach US$ 294.26 million by 2031; it is estimated to register a CAGR of 6.3% from 2023 to 2031.
Plant-Based Expression Systems for Therapeutic Protein Production Boost Asia Pacific Transient Protein Expression Market
The use of microbial or mammalian cell-based expression systems has been a common practice in recombinant protein production processes; however, plant-based expression has been promoted as a cost-effective, scalable, safe, and sustainable alternative in recent years. The duration of protein synthesis has been greatly shortened and the yield of recombinant proteins in plants has improved thanks to the creation and advancement of transient expression methods. A shift in consumer preference toward plant-based products compels pharmaceutical and biopharmaceutical companies to focus on plant-based synthesis of therapeutic proteins.
The use of plants has excellent potential for improving yields of proteins that can be administered for the prevention or treatment of human and animal diseases. The use of therapeutic proteins is likely to surge in the healthcare sector in the coming years due to the ongoing restructuring of regulatory frameworks and growing awareness about transient protein expression in plants.
Maximum scale-up possibility, low growth costs, complex protein production ability, low contamination (especially involving human pathogens) risks, and optimized growth conditions are among the key advantages associated with transient protein expression in plants. Moreover, plants are considered safer compared to other expression systems as they do not produce endotoxins and cause less harm to humans. Thus, plant-based expression systems for therapeutic protein expression are emerging as vital opportunities for the transient protein expression market growth during the forecast period.
Asia Pacific Transient Protein Expression Market Overview
The transient protein expression market in Asia Pacific is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in this region is attributed to growing biotechnology industry across several countries in Asia Pacific, increasing software product launches, and increasing developments and improvements in transient protein expression systems.
Asia Pacific Transient Protein Expression Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Transient Protein Expression Market Segmentation
The Asia Pacific transient protein expression market is categorized into product type, application, end user, and country.
Reasons to Buy:
Plant-Based Expression Systems for Therapeutic Protein Production Boost Asia Pacific Transient Protein Expression Market
The use of microbial or mammalian cell-based expression systems has been a common practice in recombinant protein production processes; however, plant-based expression has been promoted as a cost-effective, scalable, safe, and sustainable alternative in recent years. The duration of protein synthesis has been greatly shortened and the yield of recombinant proteins in plants has improved thanks to the creation and advancement of transient expression methods. A shift in consumer preference toward plant-based products compels pharmaceutical and biopharmaceutical companies to focus on plant-based synthesis of therapeutic proteins.
The use of plants has excellent potential for improving yields of proteins that can be administered for the prevention or treatment of human and animal diseases. The use of therapeutic proteins is likely to surge in the healthcare sector in the coming years due to the ongoing restructuring of regulatory frameworks and growing awareness about transient protein expression in plants.
Maximum scale-up possibility, low growth costs, complex protein production ability, low contamination (especially involving human pathogens) risks, and optimized growth conditions are among the key advantages associated with transient protein expression in plants. Moreover, plants are considered safer compared to other expression systems as they do not produce endotoxins and cause less harm to humans. Thus, plant-based expression systems for therapeutic protein expression are emerging as vital opportunities for the transient protein expression market growth during the forecast period.
Asia Pacific Transient Protein Expression Market Overview
The transient protein expression market in Asia Pacific is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in this region is attributed to growing biotechnology industry across several countries in Asia Pacific, increasing software product launches, and increasing developments and improvements in transient protein expression systems.
Asia Pacific Transient Protein Expression Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Transient Protein Expression Market Segmentation
The Asia Pacific transient protein expression market is categorized into product type, application, end user, and country.
- Based on product type, the Asia Pacific transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023.
- In terms of application, the Asia Pacific transient protein expression market is segmented into genomic research, gene therapy, bio production, cancer research, and drug development. The genomic research segment held the largest market share in 2023.
- Based on end user, the Asia Pacific transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment held the largest market share in 2023.
- By country, the Asia Pacific transient protein expression market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transient protein expression market share in 2023.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transient protein expression market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific transient protein expression market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific transient protein expression market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Asia Pacific Transient Protein Expression Market - Key Market Dynamics
5. Transient Protein Expression Market - Asia Pacific Analysis
6. Asia Pacific Transient Protein Expression Market Analysis - by Product Type
7. Asia Pacific Transient Protein Expression Market Analysis - by Application
8. Asia Pacific Transient Protein Expression Market Analysis - by End User
9. Asia Pacific Transient Protein Expression Market - Country Analysis
10. Competitive Landscape
11. Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
Some of the leading companies in the Asia Pacific Transient Protein Expression Market include:- Thermo Fisher Scientific Inc
- Merck KGaA
- QIAGEN NV
- GenScript Biotech Corporation
- Promega Corp
- Takara Bio Inc
- New England Biolabs
- Agilent Technologies Inc
- Mirus Bio LLC
- Bio-Rad Laboratories Inc
- Lonza Group AG
- MaxCyte Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 152 |
| Published | March 2025 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 181.05 Million |
| Forecasted Market Value ( USD | $ 294.26 Million |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 12 |
